Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* positive attention-deficit/hyperactivity disorder (ADHD) diagnosis with at least moderate severity~* male or female 18 to 30 years of age~* must be able to swallow capsules~* must be able to communicate effectively in English~* must not have cognitive impairment~* be reliable to keep appointments for clinic visits and all related tests~Exclusion Criteria:~* patients diagnosed with obsessive-compulsive disorder, bipolar affective disorder, or psychosis~* females who are pregnant or breastfeeding~* patients with dementia or traumatic brain injury~* patients with a history of severe allergy to atomoxetine~* have untreated hypertension or thyroid problem~* have serious medical illness including any heart, liver, kidney, respiratory, blood, endocrine, or neuromuscular diseases

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: f

Study Arms:
- Atomoxetine (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).